Fennec Pharmaceuticals Inc

Research Fennec Pharmaceuticals Inc (FRX) on Bullrun: market cap CAD 532.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFRX
• ExchangeTO
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCAD
• Market capCAD 532.17M
• Financial periodQ4 2025
• RevenueCAD 13.78M
• Net income-CAD 4.79M
• Free cash flow-CAD 5.96M
• Gross margin87.2%

Valuation Snapshot

latest market cap is CAD 532.17M.

About Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc.

Frequently asked questions

What is Fennec Pharmaceuticals Inc's market cap?

Fennec Pharmaceuticals Inc's market capitalization is CAD 532.17M.

What does Fennec Pharmaceuticals Inc do?

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients.